PET-CT Scanning Market Huge Demand in COVID-19: Regional Outlook, Trends, Key Companies Profile, CAGR and Forecast to 2028

The combined use of PET-CT scans provides the images of precise location of abnormal metabolic activity in the body.

According to a new report published by Allied Market Research, titled, “PET-CT Scanning Market by Application [Oncology, Neurology, Cardiology, and Others] and Service Provider [Hospitals, Diagnostic Centers, and Research Institutes] – Global Opportunity Analysis and Industry Forecast, 2021-2028”

Positron emission tomography-computed tomography (PET-CT) is a medical analytical technique used to examine the metabolic activity of tissues. This technique makes the use of PET scanner and an X-ray CT scanner. The PET scanners are used to measure body functions, such as blood flow, oxygen usage, and glucose metabolism, whereas CT imaging uses X-ray equipment to produce pictures of organs to observe the functioning of tissues and organs. The combined use of PET-CT scans provides the images of precise location of abnormal metabolic activity in the body.

Download Report Sample (320 Pages PDF with Insights) https://www.alliedmarketresearch.com/request-sample/2721

The global market size of PET-CT Scanning is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2028 with a CAGR of XX% from 2021 to 2028.

The global PET-CT scanning market is segmented based on application, service provider, and geography.

Applications covered in this study include oncology, neurology, cardiology, and others. On the basis of service provider, the market is categorized into hospitals, diagnostic centers, and research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The growth of the global PET-CT scanning market is driven by rise in prevalence of chronic illnesses throughout the world, growth in demand for effective diagnostic systems, and increased coverage for PET-CT scanning under Medicare. Rise in use of PET-CT for cancer diagnosis is expected to further boost the market growth. Moreover, development of newer products and increase in investments in R&D by companies contribute towards the revenue growth of the market. However, limited shelf life and inadequate availability of radiopharmaceuticals are expected to hinder the market growth.

The Major Key Players Are:

Toshiba Corporation, General Electric Co, Hitachi, Siemens AG, Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd, and Mediso Ltd

Key Benefits

  • This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
  • The global market is analyzed with respect to application, service provider, and geography.
  • In-depth analysis based on geography facilitates to analyze the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Inquire More About This Report Before Making Decision To Purchase: https://www.alliedmarketresearch.com/purchase-enquiry/2721

PET-CT Scanning Market Key Segments:

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Others

By Service Provider

  • Hospitals
  • Diagnostic Centers
  • Research Institutes

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Republic of South Africa
    • Saudi Arabia
    • Rest of LAMEA

Similar Reports:

Respiratory Care Devices Market : https://www.pharmiweb.com/press-release/2020-09-14/respiratory-care-devices-market-to-see-record-break-revenue-2130-billion-by-2022

Diabetic Retinopathy Market : https://www.pharmiweb.com/press-release/2020-09-14/diabetic-retinopathy-market-value-to-grasp-249-billion-by-2022-at-cagr-of-144-amr

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Related Articles

Back to top button